Closing the Innovation Gap: Why Drug Discovery Breakthroughs Are Failing to Reach Patients
Why do so many drug discovery breakthroughs fail to reach patients? Trisha Pillay speaks with Christian Nkanga to find out.
Discover innovative solutions and insights from leading pharmaceutical and life sciences companies driving advances in drug development, biotechnology, healthcare, and scientific innovation.
Type at least 2 characters to search
Closing the Innovation Gap: Why Drug Discovery Breakthroughs Are Failing to Reach Patients
Why do so many drug discovery breakthroughs fail to reach patients? Trisha Pillay speaks with Christian Nkanga to find out.
Anthropic’s Big AI Drug Discovery Announcement
Anthropic's new drug discovery programme marks a strategic shift from sole AI software provider to active R&D participant. Here's what it means for pharmaceutical innovation.
Anthropic’s Gates Foundation Partnership and Healthcare AI
See how Anthropic's Gates Foundation partnership and Long-Term Benefit Trust could lead the way in shaping responsible AI governance across healthcare innovation.
Close the Drug Discovery Loop by Leveraging the DMTA Cycle
The DMTA cycle is the engine of modern pharma R&D. Learn how integrated DMTA workflows reduce early-stage attrition and compress drug discovery timelines.
Preclinical vs Clinical Research Strategy for Drug Development
Explore the critical differences between preclinical vs clinical research, and how closing the translation gap can reduce drug development attrition and improve R&D decision-making.
Modern Drug Discovery Challenges Demand a New Pharma Paradigm
Explore the biggest drug discovery challenges facing pharma today, from translational gaps to AI integration, and why a new pharma paradigm is needed.
Shahid Siddiqui
Deepankar Nayak
Kimberly S. Clarke
Dr. Claus Bolte
No result found for